P Youn1, H Li, M T Milano, M Stovall, L S Constine, L B Travis. 1. Department of Radiation Oncology and Rubin Center for Cancer Survivorship, University of Rochester Medical Center, Rochester, NY 14642, USA.
Abstract
BACKGROUND: The increased risk of gastrointestinal (GI) cancers after Hodgkin's lymphoma (HL) is well established. However, no large population-based study has described the actuarial survival after subsequent GI cancers in HL survivors (HL-GI). PATIENTS AND METHODS: For 209 patients with HL-GI cancers (105 colon, 35 stomach, 30 pancreas, 21 rectum, and 18 esophagus) and 484 165 patients with first primary GI cancers (GI-1), actuarial survival was compared, accounting for age, gender, race, GI cancer stage, radiation for HL, and other variables. RESULTS: Though survival of HL patients who developed localized stage colon cancer was similar to that of the GI-1 group, overall survival (OS) of HL patients with regional or distant stage colon cancer was reduced [hazard ratio, (HR)=1.46, P=0.01]. The HL survivors with regional or distant stage colon cancer in the transverse segment had an especially high risk of mortality (HR: 2.7, P=0.001 for OS). For localized stomach cancer, OS was inferior among HL survivors (HR=3.46, P=0.006). CONCLUSIONS: The HL patients who develop GI cancer experience significantly reduced survival compared with patients with a first primary GI cancer. Further research is needed to explain the inferior survival of HL patients and to define selection criteria for cancer screening in HL survivors.
BACKGROUND: The increased risk of gastrointestinal (GI) cancers after Hodgkin's lymphoma (HL) is well established. However, no large population-based study has described the actuarial survival after subsequent GI cancers in HL survivors (HL-GI). PATIENTS AND METHODS: For 209 patients with HL-GI cancers (105 colon, 35 stomach, 30 pancreas, 21 rectum, and 18 esophagus) and 484 165 patients with first primary GI cancers (GI-1), actuarial survival was compared, accounting for age, gender, race, GI cancer stage, radiation for HL, and other variables. RESULTS: Though survival of HL patients who developed localized stage colon cancer was similar to that of the GI-1 group, overall survival (OS) of HL patients with regional or distant stage colon cancer was reduced [hazard ratio, (HR)=1.46, P=0.01]. The HL survivors with regional or distant stage colon cancer in the transverse segment had an especially high risk of mortality (HR: 2.7, P=0.001 for OS). For localized stomach cancer, OS was inferior among HL survivors (HR=3.46, P=0.006). CONCLUSIONS: The HL patients who develop GI cancer experience significantly reduced survival compared with patients with a first primary GI cancer. Further research is needed to explain the inferior survival of HL patients and to define selection criteria for cancer screening in HL survivors.
Authors: A J Swerdlow; J A Barber; G V Hudson; D Cunningham; R K Gupta; B W Hancock; A Horwich; T A Lister; D C Linch Journal: J Clin Oncol Date: 2000-02 Impact factor: 44.544
Authors: F E van Leeuwen; W J Klokman; M B Veer; A Hagenbeek; A D Krol; U A Vetter; M Schaapveld; P van Heerde; J M Burgers; R Somers; B M Aleman Journal: J Clin Oncol Date: 2000-02 Impact factor: 44.544
Authors: N Uemura; S Okamoto; S Yamamoto; N Matsumura; S Yamaguchi; M Yamakido; K Taniyama; N Sasaki; R J Schlemper Journal: N Engl J Med Date: 2001-09-13 Impact factor: 91.245
Authors: Andrea K Ng; M Patricia Bernardo; Edie Weller; Kendall H Backstrand; Barbara Silver; Karen C Marcus; Nancy J Tarbell; Jonathan Friedberg; George P Canellos; Peter M Mauch Journal: J Clin Oncol Date: 2002-04-15 Impact factor: 44.544
Authors: Graça M Dores; Catherine Metayer; Rochelle E Curtis; Charles F Lynch; E Aileen Clarke; Bengt Glimelius; Hans Storm; Eero Pukkala; Flora E van Leeuwen; Eric J Holowaty; Michael Andersson; Tom Wiklund; Timo Joensuu; Mars B van't Veer; Marilyn Stovall; Mary Gospodarowicz; Lois B Travis Journal: J Clin Oncol Date: 2002-08-15 Impact factor: 44.544
Authors: Andrea K Ng; M V Patricia Bernardo; Edie Weller; Kendall Backstrand; Barbara Silver; Karen C Marcus; Nancy J Tarbell; Mary Ann Stevenson; Jonathan W Friedberg; Peter M Mauch Journal: Blood Date: 2002-09-15 Impact factor: 22.113
Authors: Alexandra W van den Belt-Dusebout; Berthe M P Aleman; Gijs Besseling; Marie L de Bruin; Michael Hauptmann; Mars B van 't Veer; Ronald de Wit; Jacques G Ribot; Evert M Noordijk; J Martijn Kerst; Jourik A Gietema; Flora E van Leeuwen Journal: Int J Radiat Oncol Biol Phys Date: 2009-12-01 Impact factor: 7.038
Authors: Lindsay M Morton; Graça M Dores; Rochelle E Curtis; Charles F Lynch; Marilyn Stovall; Per Hall; Ethel S Gilbert; David C Hodgson; Hans H Storm; Tom Børge Johannesen; Susan A Smith; Rita E Weathers; Michael Andersson; Sophie D Fossa; Michael Hauptmann; Eric J Holowaty; Heikki Joensuu; Magnus Kaijser; Ruth A Kleinerman; Frøydis Langmark; Eero Pukkala; Leila Vaalavirta; Alexandra W van den Belt-Dusebout; Joseph F Fraumeni; Lois B Travis; Berthe M Aleman; Flora E van Leeuwen Journal: J Clin Oncol Date: 2013-08-26 Impact factor: 44.544
Authors: Lisanne Sara Rigter; Frank G J Kallenberg; Barbara Bastiaansen; Theo A M van Os; Floor E van Leeuwen; Monique Esther van Leerdam; Evelien Dekker Journal: BMC Cancer Date: 2016-11-08 Impact factor: 4.430
Authors: Lisanne S Rigter; Manon C W Spaander; Leon M Moons; Tanya M Bisseling; Berthe M P Aleman; Jan Paul de Boer; Pieternella J Lugtenburg; Cecile P M Janus; Eefke J Petersen; Judith M Roesink; John M M Raemaekers; Richard W M van der Maazen; Annemieke Cats; Eveline M A Bleiker; Petur Snaebjornsson; Beatriz Carvalho; Iris Lansdorp-Vogelaar; Katarzyna Jóźwiak; Hein Te Riele; Gerrit A Meijer; Flora E van Leeuwen; Monique E van Leerdam Journal: BMC Cancer Date: 2017-02-07 Impact factor: 4.430
Authors: Lisanne S Rigter; Manon C W Spaander; Berthe M P Aleman; Tanya M Bisseling; Leon M Moons; Annemieke Cats; Pieternella J Lugtenburg; Cecile P M Janus; Eefke J Petersen; Judith M Roesink; Richard W M van der Maazen; Petur Snaebjornsson; Ernst J Kuipers; Marco J Bruno; Evelien Dekker; Gerrit A Meijer; Jan Paul de Boer; Flora E van Leeuwen; Monique E van Leerdam Journal: Cancer Date: 2018-12-18 Impact factor: 6.860
Authors: Andrea Gini; Reinier G S Meester; Homa Keshavarz; Kevin C Oeffinger; Sameera Ahmed; David C Hodgson; Iris Lansdorp-Vogelaar Journal: J Natl Cancer Inst Date: 2019-11-01 Impact factor: 13.506
Authors: Lisanne S Rigter; Petur Snaebjornsson; Efraim H Rosenberg; Estelle Altena; Nicole C T van Grieken; Berthe M P Aleman; Jan M Kerst; Lindsay Morton; Michael Schaapveld; Gerrit A Meijer; Flora E van Leeuwen; Monique E van Leerdam Journal: PLoS One Date: 2022-07-25 Impact factor: 3.752
Authors: Lisanne S Rigter; Michael Schaapveld; Cecile P M Janus; Augustinus D G Krol; Richard W M van der Maazen; Judith Roesink; Josee M Zijlstra; Gustaaf W van Imhoff; Philip M P Poortmans; Max Beijert; Pieternella J Lugtenburg; Otto Visser; Petur Snaebjornsson; Anna M van Eggermond; Berthe M P Aleman; Flora E van Leeuwen; Monique E van Leerdam Journal: Cancer Med Date: 2018-12-27 Impact factor: 4.452